Mechanical Ventilation Weaning

Introduction to Weaning

• Mechanical ventilation weaning is a critical process that requires careful assessment and planning to ensure successful extubation, as recommended by the Society of Critical Care Medicine 1, 2
• Approximately 70% of patients in the ICU can be extubated within 24 hours after the first weaning trial, which is considered a short weaning period, while about 15% of patients require up to 6 days to wean, and patients who require 7 days or more to wean have poorer outcomes 3

Assessment of Readiness for Extubation

• Measuring parameters such as the frequency/tidal volume ratio (f/VT) during the first minute of spontaneous breathing is not recommended, as the respiratory drive may still be suppressed, according to the American Thoracic Society 4
• Measuring f/VT after 30-60 minutes provides a better prediction of extubation outcome, as suggested by the American Thoracic Society 4
• Women with narrow endotracheal tubes (≤ 7 mm internal diameter) may have a higher rate of false negatives in f/VT assessment, as noted by the American Thoracic Society 4
• Patient selection for SBT should be based on readiness criteria, including resolution of underlying respiratory failure, FiO₂ ≤ 0.50, PEEP ≤ 5-8 cmH₂O, hemodynamic stability, and ability to initiate respiratory effort, as recommended by the Society of Critical Care Medicine 1, 5, 6
• Monitor patients for signs of poor tolerance during SBTs, including respiratory rate > 35 breaths/min, SpO₂ < 90%, heart rate > 140 beats/min, and systolic BP > 180 mmHg or < 90 mmHg 6

Spontaneous Breathing Trials (SBTs)

• A T-piece trial involves disconnecting the patient from the ventilator and providing oxygen through a T-shaped connector attached to the endotracheal tube without any pressure support, and is considered a more demanding assessment of a patient's ability to breathe independently compared to pressure-augmented SBTs 6, 7
• Pressure-augmented SBTs (5-8 cmH₂O) are more likely to be successful and lead to higher rates of extubation success compared to T-piece trials, as recommended by the American Thoracic Society 7
• The standard duration for T-piece trials ranges from 30-120 minutes, with evidence suggesting 60-120 minutes may be more appropriate for thorough assessment 6

Ventilator Management

• Implement a structured ventilator liberation protocol, including daily screening for weaning readiness, SBTs with pressure augmentation, and assessment for extubation if SBT is successful, to optimize patient outcomes and minimize ventilator days, according to the Society of Critical Care Medicine 1, 2
• Implement a lung-protective ventilation strategy with low tidal volume (4-6 ml/kg predicted body weight), plateau pressure <30 cmH₂O, and appropriate PEEP to prevent alveolar collapse, as recommended by the Military Medical Research and the Society of Critical Care Medicine 8, 9
• Target SpO₂ of 88-90% (approximating PaO₂ of 60 mmHg) and use lowest effective FiO₂ (ideally <0.60) to minimize oxygen toxicity, according to the Intensive Care Medicine 6
• Minimize sedation in mechanically ventilated patients, as recommended by the Society of Critical Care Medicine 5
• Avoid routine endotracheal suctioning and perform only when indicated, as recommended by the American Thoracic Society 2
• Use humidification, as recommended by the American Association for Respiratory Care 2
• Elevating the head of bed to 30-45 degrees is recommended to reduce the risk of ventilator-associated pneumonia, as suggested by the Critical Care Medicine society and the Centers for Disease Control and Prevention 5, 4

Special Populations

• Patients with neuromuscular disease may benefit from non-invasive ventilation (NIV) to facilitate weaning, as recommended by the European Society of Intensive Care Medicine 2
• NIV can be used to aid weaning from invasive mechanical ventilation, particularly in patients with chronic obstructive pulmonary disease (COPD) 10, 11
• Consider prophylactic non-invasive ventilation (NIV) immediately after extubation for high-risk patients, as recommended by various medical organizations 2, 4
• Consider modified approaches for special populations, including COPD patients who may benefit from pressure-augmented SBTs, difficult-to-wean patients who may require multiple SBTs, and cardiac patients who require monitoring for signs of cardiac failure during SBT, as recommended by the European Respiratory Society 12, 13
• For patients with Obesity Hypoventilation Syndrome (OHS), consider pressure-controlled mechanical ventilation, higher PEEP settings (10-15 cmH₂O), and forced diuresis to address fluid overload, as suggested by the Thorax journal 10
• For patients with COPD-related respiratory failure, use ventilator settings that allow for longer expiration and shorter inspiration, and avoid further hyperinflation and increases in intrinsic PEEP, as recommended by the European Respiratory Journal 13

Extubation and Weaning Outcomes

• If SBT is successful, proceed with comprehensive Extubation Readiness Test (ERT) assessment, as SBT success does not guarantee extubation success, with studies showing 10-20% of patients with successful SBTs still failing extubation, as reported by the European Society of Anaesthesiology 14
• The following table summarizes the weaning outcomes and duration:

• The American Society of Anesthesiologists recommends considering early tracheostomy (<7 days) for patients with anticipated prolonged weaning 15
• Early tracheostomy (<7 days) should be considered in patients with high-level injuries (C2-C5) 15
• For patients with cervical spinal cord injuries, the use of an abdominal containment belt during periods of spontaneous breathing, active physiotherapy, and mechanical insufflation/exsufflation devices is recommended 15
• Two primary methods can be used based on patient needs and family preferences: terminal extubation (immediate removal of endotracheal tube) and terminal weaning (gradual reduction of inspired oxygen concentration and/or mandatory ventilator rate) 16
• Discontinue neuromuscular blockers if in use and allow effects to wear off, and administer anticipatory titrated doses of opioids and benzodiazepines to alleviate dyspnea 16
• Continue to titrate opioids and benzodiazepines to maintain control of any signs of discomfort, and regularly assess for signs of dyspnea and pain after removal from assisted breathing 16